From : EASL Office <ILC.information@easloffice.eu>
To : eadamia@moh.gov.ge
Subject : Digital ILC 2020 Viral Hepatitis track revealed
Received On : 23.07.2020 09:29
Digital ILC 2020 Viral Hepatitis track revealed
23 July 2020
Digital ILC 2020

World Hepatitis Day is around the corner, taking place next Tuesday, 28 July. EASL is part of the worldwide action plan calling for elimination of viral hepatitis as a global public health threat by 2030. Hence, Digital ILC 2020 will provide a platform for leading experts to discuss the remaining obstacles to HCV elimination and review the upcoming treatments and new insights for other forms of viral hepatitis.
Digital ILC 2020 preview: 
Highlights in Hepatitis B and D drug development
What is the latest in viral hepatitis research? What developments are in the pipeline for Hepatitis B and D? 
To find out how this area of research is evolving, watch this video, “Highlights in Hepatitis B and D drug development” presented by the session Co-Chair, Dr Markus Cornberg. 
Viral Hepatitis track at Digital ILC 2020
The Digital ILC 2020 Viral Hepatitis track provides updates on the progress towards HCV elimination and highlights the latest breakthroughs in finding a cure for Hepatitis B.

The sessions will provide a detailed overview and latest science on topics such as:
  • Hepatitis B and D - Translational  and drug development
  • Hepatitis C - Therapy and resistance, long-term management, post-SVR and long-term follow up as well as elimination
  • Hepatitis E - From virology to treatment
  • Hepatitis: Immunology
  • And more...
Throughout the event, you can attend a wide range of sessions to learn and interact with 9,000+ members of the hepatology community.
Click on the images below to discover the content for each type of session.
Abstract session Viral Hepatitis
Interactive sessions Viral Hepatitis
Poster tours Viral Hepatitis
wrap up session Viral Hepatitis
Meet the experts session
 
"Meet the experts" is an ideal opportunity for you to learn from some of the biggest names in hepatology and to meet them in an engaging and interactive setting!
Meet the experts Viral Hepatitis
See all "Meet the experts" sessions
Zoom on a session
HEV - From virology to treatment
 
Hepatitis E virus is one of the most common causes of acute hepatitis and jaundice in the world. In addition, HEV can cause diverse neurological as well as other extrahepatic manifestations, and trigger acute-on-chronic liver failure in patients with pre-existing cirrhosis.

This interactive session will provide a state-of-the-art update on Hepatitis E, including an overview on current hot topics in this area, the molecular virology and pathogenesis of hepatitis E, as well as the prevention and treatment of HEV infection. Key points will include:
  • providing a primer on the epidemiology, clinical manifestations, diagnosis, and management of acute and chronic hepatitis E
  • highlighting advances in research on the HEV life cycle and the identification of targets for antiviral intervention
  • discussing the immune response to HEV as well as determinants of infection outcome and
  • providing an overview of current and emerging preventive as well as therapeutic strategies.
Interactive session on HEV
Browse the scientific programme of
The Digital ILC 2020
Our carefully curated selection of original live and on-demand content brings you a congress programme of unprecedented global relevance, reach, and convenience. Whether you are in the Americas, Africa, Asia, Europe, or Oceania, all the key presentations and much more will be just a click away.
Digital ILC programme
Register now for The Digital ILC 2020
We trust that this glimpse of key sessions dedicated to Viral Hepatitis has convinced you to register for The Digital ILC 2020.

The Digital ILC 2020 is the key event for you to learn, share, and interact with some of the greatest names in hepatology. In addition, the event showcases the latest in science and the most important updates in liver disease management. All these at a global level, thanks to:
  • 159 chairs from 18 countries
  • Abstracts submitter authors from 50 countries
  • Abstract presenters from 56 countries
  • 98 sessions
  • Over 100 hours of video content
  • Faculty diversity: 88 women and 125 men
Very special registration rates are now available, starting at 100 euros. 
I would like to register
Do you need more reasons to register?
Here are our top 7 reasons to attend the Digital ILC 2020:
  1. 100+ hours of cutting-edge scientific content 
  2. all the scientific content will only be available to registered participants
  3. registration includes the exclusive access to the full on-demand content until 31 December 2020
  4. dedicated session on COVID-19 and the liver
  5. scientific programme with global reach and relevance
  6. digital platform with high interactivity, close to onsite experience
  7. wide range of sessions with engaging scientific and educational content
                                                  
Prepare for The Digital ILC 2020
Selected articles from the Journal of Hepatology:
Selected resources from EASL Campus
On EASL Campus, discover over 530 dedicated resources on Viral Hepatitis.
(Re)discover the “Best of ILC 2019” Slide Deck
Selected EASL resources
EASL Recommendations on Treatment of Hepatitis C 

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. As a result, in 2018, worldwide there were approximately 71 million chronically infected individuals. 

EASL Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.

Read EASL’s Recommendations on Treatment of HCV
EASL Guidelines for Hepatitis B

Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccination policies and migration. Most importantly, all patients with chronic HBV infection are at increased risk of progression to cirrhosis and hepatocellular carcinoma (HCC). 

Therefore, the EASL Guidelines for Hepatitis B present updated recommendations for the optimal management of HBV infection.

Read EASL’s Guidelines for HBV
Download the EASL app 
Access event info, EASL Campus and stay informed with the latest messages and news.

  
For the latest news on The Digital ILC 2020, follow the official #ILC2020 on Twitter

@EASLnews and @EASLedu
Twitter
Facebook
LinkedIn
Website
Share with a friend or colleague Share with a friend or colleague
EASL’s mission is supported by an unrestricted education grant from Abbvie and Bristol-Myers Squibb.

EASL, The Home of Hepatology
7 rue Daubin, 1203 Geneva, Switzerland

+41 22 807 03 60
www.easl.eu
easloffice@easloffice.eu

Update your preferences or unsubscribe